Literature DB >> 14650117

Complete response of brain metastases originating in breast cancer to capecitabine therapy.

Nava Siegelmann-Danieli1, Moshe Stein, Jacob Bar-Ziv.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14650117

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  6 in total

Review 1.  Radiotherapy and chemotherapy of brain metastases.

Authors:  R Soffietti; A Costanza; E Laguzzi; M Nobile; R Rudà
Journal:  J Neurooncol       Date:  2005-10       Impact factor: 4.130

2.  Systemic high-dose intravenous methotrexate for central nervous system metastases.

Authors:  Andrew B Lassman; Lauren E Abrey; Gaurav D Shah; Gaurav G Shah; Katherine S Panageas; Martin Begemann; Mark G Malkin; Jeffrey J Raizer
Journal:  J Neurooncol       Date:  2006-07       Impact factor: 4.130

Review 3.  Systemic therapy of brain metastases: non-small cell lung cancer, breast cancer, and melanoma.

Authors:  Marc C Chamberlain; Christina S Baik; Vijayakrishna K Gadi; Shailender Bhatia; Laura Q M Chow
Journal:  Neuro Oncol       Date:  2017-01       Impact factor: 12.300

4.  Capecitabine therapy of central nervous system metastases from breast cancer.

Authors:  Meltem Ekenel; Adilia M Hormigo; Scott Peak; Lisa M Deangelis; Lauren E Abrey
Journal:  J Neurooncol       Date:  2007-07-05       Impact factor: 4.130

5.  Concurrent capecitabine and whole-brain radiotherapy for treatment of brain metastases in breast cancer patients.

Authors:  Cyrus Chargari; Youlia M Kirova; Véronique Diéras; Pablo Castro Pena; Pablo Castro Pena; Francois Campana; Paul H Cottu; JeanYves Pierga; Alain Fourquet
Journal:  J Neurooncol       Date:  2009-01-25       Impact factor: 4.130

6.  Complete Radiologic Response of Bulky Cerebral Metastases From Newly Diagnosed HER2-Positive Breast Cancer to Upfront Trastuzumab-Based Chemotherapy.

Authors:  Daniel Brungs; Victor Sze; Louise Emmett; Richard J Epstein
Journal:  World J Oncol       Date:  2013-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.